Crown Laboratories Acquires Eclipse Medcorp's Aesthetics Assets

Encore Acquires Eclipse to Expand UK Event Production Capabilities

November 20, 2025

Media & Entertainment

Encore, a global event production and technology company headquartered in Schiller Park, Illinois, has acquired Eclipse, a Beckenham, United Kingdom–based creative technical production firm founded in 1988. The acquisition strengthens Encore's presence and capabilities in the UK market—adding Eclipse's production, scenic and in-house creative expertise and venue relationships with London hotels and stadiums.

Crown Laboratories Acquires Revance Therapeutics in $924M Merger

August 12, 2024

Healthcare Services

Crown Laboratories, Inc. entered into a merger agreement to acquire Revance Therapeutics, Inc. for $6.66 per share in cash, representing an enterprise value of $924 million. The deal closed after Crown commenced a tender offer and then completed a second-step merger, with Revance becoming wholly owned by Crown and delisted from Nasdaq.

Crown Aesthetics (Crown Laboratories) Acquires Select Assets from Healeon LLC (Bimini Health Tech)

July 23, 2024

Medical Devices

Crown Aesthetics, a Crown Laboratories company, has acquired select assets and technology from Healeon LLC, a subsidiary of Bimini Health Tech, to strengthen its ProGen PRP Eclipse platelet-rich plasma (PRP) offering. The asset purchase expands Crown's PRP device portfolio, supports new product development, and aims to extend Crown's geographic and production capabilities in the regenerative and aesthetic medicine markets.

Cushing Terrell Acquires Eclipse Engineering

July 1, 2024

Engineering Services

Multidisciplinary design firm Cushing Terrell has acquired structural engineering firm Eclipse Engineering, bringing Eclipse's regional offices and specialty structural capabilities into Cushing Terrell's platform. Eclipse's leadership will join Cushing Terrell's structural engineering practice to expand capabilities in mass timber, tilt‑up concrete, seismic retrofits, and other specialty services.

Crown Laboratories Acquires Xycrobe Therapeutics, Inc.

May 22, 2019

Biotechnology

Crown Laboratories, a privately held skin care company based in Johnson City, Tennessee, has acquired Xycrobe Therapeutics, a developer of skin microbiome-based biotherapeutic technology. Crown plans to integrate Xycrobe’s microbiome platform and scientific team into its R&D organization to expand therapeutic and consumer skin-care capabilities; financial terms were not disclosed.

Crown Laboratories Acquires Keri Brand from GlaxoSmithKline

May 1, 2019

Consumer Products

Crown Laboratories acquired the North American rights to the Keri skin care brand from GlaxoSmithKline and concurrently received an equity investment from Greenspring Associates. Existing investors Hildred Capital Partners and Montreux Equity Partners provided financing in connection with the transaction; financial terms were not disclosed.